scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.HOC.2015.07.009 |
P698 | PubMed publication ID | 26568546 |
P2093 | author name string | John B Sunwoo | |
David W Schoppy | |||
P2860 | cites work | Targeting CD137 enhances the efficacy of cetuximab. | Q33872482 |
P433 | issue | 6 | |
P921 | main subject | immunotherapy | Q1427096 |
P304 | page(s) | 1033-1043 | |
P577 | publication date | 2015-10-20 | |
P1433 | published in | Hematology / Oncology Clinics of North America | Q15749192 |
P1476 | title | Immunotherapy for Head and Neck Squamous Cell Carcinoma. | |
P478 | volume | 29 |
Q50066270 | BCG immune activation reduces growth and angiogenesis in an in vitro model of head and neck squamous cell carcinoma |
Q39190801 | Biological mechanisms of immune escape and implications for immunotherapy in head and neck squamous cell carcinoma |
Q59477539 | Costimulatory and coinhibitory immune checkpoint receptors in head and neck cancer: unleashing immune responses through therapeutic combinations |
Q90419584 | Current Perspectives in Cancer Immunotherapy |
Q39084115 | Current insights into the aetiology, pathobiology, and management of local disease recurrence in squamous cell carcinoma of the vulva |
Q90734623 | Distinguishing Features of Cetuximab and Panitumumab in Colorectal Cancer and Other Solid Tumors |
Q33650470 | Evidence-Based Treatment Options in Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck |
Q57475700 | Immunotherapy for Brain Tumors |
Q39308337 | Immunotherapy for Head and Neck Squamous Cell Carcinoma: A Review of Current and Emerging Therapeutic Options |
Q40208391 | PDCD1 (PD-1) promoter methylation predicts outcome in head and neck squamous cell carcinoma patients |
Q46113809 | Rationale for combination of therapeutic antibodies targeting tumor cells and immune checkpoint receptors: Harnessing innate and adaptive immunity through IgG1 isotype immune effector stimulation |
Q91895909 | The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC) |
Q90649378 | The multifarious roles of the chemokine CXCL14 in cancer progression and immune responses |
Search more.